|
| 华东医药(000963)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2024-11-15 | 125.57 | 0.07% | 175237.47 | 195.28 | 175090.40 | 99.80% | 股权激励限售股份 | | 2024-09-30 | 21.50 | 0.01% | 175111.90 | 320.86 | 175090.40 | 99.80% | 股权激励限售股份 | | 2023-12-05 | 122.09 | 0.07% | 175094.80 | 347.74 | 174972.70 | 99.73% | 股权激励限售股份 | | 2019-02-11 | 15599.47 | 10.70% | 145817.46 | 0.00 | 145817.46 | 100.00% | 增发A股原股东配售上市 | | 2014-09-30 | 15410.74 | 35.50% | 43406.00 | 0.00 | 43406.00 | 100.00% | 股权分置限售流通 | | 2010-09-02 | 3352.67 | 7.72% | 27995.26 | 15410.74 | 43406.00 | 100.00% | 股权分置限售流通 | | 2009-01-06 | 2170.30 | 5.00% | 24642.58 | 18763.42 | 43406.00 | 100.00% | 股权分置限售流通 | | 2007-11-06 | 4430.86 | 10.21% | 22472.28 | 20933.72 | 43406.00 | 100.00% | 股权分置限售流通 |
|